Biological Information

Background Information:

VIP1 (VPAC1) receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. The VIP receptor family includes receptors for pituitary adenylate cyclase-activating polypeptide (PACAP), secretin, glucagon-like peptide-1 (GLP-1), calcitonin, parathyroid hormone and growth hormone-releasing factor, which are coupled preferentially to GaS to stimulate adenylate cyclase and increase cAMP levels. VIP1 receptors are widely distributed in the central nervous system, in peripheral tissues and in T lymphocytes.

No. of Assays on Panel:

2

Assays on Panel:

Family

GPCR

Name

Item

486

Protein

VIP1 (VPAC1)

Organism

Human

Assay Sub Type

Cell Based

Family

GPCR

Name

Item

515

Protein

VIP1 (VPAC1)

Organism

Human

Assay Sub Type

Cell Based

Family:

GPCR

Sub Family:

VIP and PACAP

Class:

Class B

Protein Name:

VIP1 (VPAC1)

Uniprot Number:

P32241

Protein Aliases:

PVR2|HVR1|RDC1|VIP and PACAP receptor 1|PACAP-R2|pituitary adenylate cyclase-activating polypeptide type II receptor|VIP-R1

Gene Name:

VIPR1

Gene ID:

7433

Gene Aliases:

VPAC1|RDC1|HVR1|VPAC1R

Organism:

Human

Cell Type:

HT-29

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Agonist & Antagonist

Detection Method:

HTRF

Testing Information

Incubation:

10 min at 37°C

Control Activator:

VIP (1 nM)

Test Concentration / Dose:

Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.

Test Sample Requirements:

Minimum for 1) Screen: 60 µL of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM finµL testing. 2) Dose Response: 90 µL of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.

Minimum Order Quantity:

16

Turnaround Time

Standard:

15 Business Days

Clinical Relevance

Therapeutic Area:

Inflammation/Allergy

Adverse / Beneficial Action:

VIP1 receptor agonism may reduce immune mediated brain, pulmonary and gastrointestinal inflammation, gastrointestinal transit and pulmonary hypertension and cause vasodilation.

Additional Information

Brand:

LeadHunter

Testing Location:

France - Celle L'Evescault

RELATED SOLUTIONS

Item: 157
Item: 486
Item: 515